Skolyn Headquarters & Office Locations

Skolyn (Private) is headquartered in Baku, Baku, Azerbaijan. Founded in 2025, the company operates across 1 countries with approximately 30 employees worldwide.

Where is Skolyn's main office?

Skolyn's main headquarters office is located at 44 Jafar Jabbarli Street Baku, Baku, Baku 1065. This serves as the company's primary corporate address and is home to its executive leadership team.

Skolyn regional offices

Beyond its headquarters in Baku, Skolyn maintains 1 offices across 1 countries. Regional offices span 1 countries.

Skolyn contact information

The main switchboard for Skolyn headquarters can be reached at +994515396228. For investor relations, visit skolyn.se/investor-relations.

What does Skolyn do?

Skolyn is a clinical-stage computational imaging and artificial intelligence company architecting the foundational technologies for the next era of diagnostic medicine. The company's core mission is to resolve the systemic inefficiencies confronting modern radiology, including unsustainable workloads, high clinician burnout rates, and persistent diagnostic error rates. Skolyn's key technological differentiator is its ''Clarity Engine,'' a suite of deep learning models trained on vast datasets of raw k-space data (from initiatives like the fastMRI+ project), which enables the reconstruction of medical images from undersampled data. This technology can significantly reduce MRI scan times while simultaneously improving image quality. Built upon this foundation, the Skolyn Diagnostic Suite provides clinicians with a universal, multi-modal analysis platform with an initial focus on Musculoskeletal (Knee), Neurology (Brain), and Oncology (Prostate, Breast) MRI. Every module is built upon the inviolable principle of Explainable AI (XAI), providing a complete dossier of evidence for each finding to foster warranted clinical trust. The company operates on a tiered, B2B Software-as-a-Service (SaaS) model, providing annual licenses to hospitals and clinical centers. Skolyn is strategically aligned with national digital health initiatives and is positioned to become a leader in the rapidly growing field of AI-augmented, high-performance medicine.